Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Lexaria Bioscience Corp. (LEXX) had Return on Tangible Equity of -519.03% for the most recently reported fiscal year, ending 2025-08-31.
| Income Statement Financials | |
$0.71M |
|
$-11.90M |
|
$0.00M |
|
$0.70M |
|
$12.59M |
|
$-11.88M |
|
$-0.03M |
|
$-11.91M |
|
$-11.88M |
|
$-11.91M |
|
$-11.91M |
|
$-11.91M |
|
$-11.88M |
|
$-11.88M |
|
$-11.79M |
|
18.00M |
|
18.00M |
|
$-0.66 |
|
$-0.66 |
|
| Balance Sheet Financials | |
$3.47M |
|
$0.23M |
|
$0.71M |
|
$4.18M |
|
$1.49M |
|
-- |
|
$0.08M |
|
$1.57M |
|
$2.60M |
|
$2.29M |
|
$2.60M |
|
19.56M |
|
| Cash Flow Statement Financials | |
$-10.45M |
|
$-0.24M |
|
$6.05M |
|
$6.50M |
|
$1.80M |
|
$-4.70M |
|
$0.86M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
99.61% |
|
-1683.01% |
|
-1683.01% |
|
-1670.57% |
|
-1687.36% |
|
-1686.00% |
|
$-10.47M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
-- |
|
1.92 |
|
190.46 |
|
-457.65% |
|
|
Return on Tangible Equity |
-519.03% |
-285.30% |
|
-457.65% |
|
$0.13 |
|
$-0.58 |
|
$-0.58 |
|